H Lundbeck B (LUN)

172.7
0.0(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.0/0.0
  • Day's Range:
    170.9 - 174.9
High dividend Yield

Dividend yield shows how much a company pays its shareholders in dividends annually per dollar invested. It reflects how much an investor will earn aside from any capital gains in the stock.

LUN Overview

Prev. Close
171.1
Day's Range
170.9-174.9
Revenue
17.62B
Open
171.1
52 wk Range
142.6-204
EPS
1.61
Volume
0
Market Cap
34.31B
Dividend (Yield)
2.00
(5.79%)
Average Vol. (3m)
385,512
P/E Ratio
15.38
Beta
1.02
1-Year Change
6.9%
Shares Outstanding
198,646,107
Next Earnings Date
-
What is your sentiment on H Lundbeck B?
or
Vote to see community's results!

H Lundbeck B Company Profile

H Lundbeck B Company Profile

Employees
5437
Market
Denmark
  • Type:Equity
  • Market:Denmark
  • ISIN:DK0010287234
  • S/N:199148222

H Lundbeck A/S is a Denmark-based company active in the pharmaceuticals industry. It is engaged in the research, development, manufacture and marketing of pharmaceuticals for the treatment of brain disorders, such as Alzheimer’s disease, Bipolar disorder, depression, epilepsy, Huntington’s disease, Parkinson’s disease and schizophrenia. Its product portfolio includes: Cipralex for the treatment of depression and anxiety disorders, Ebixa for the treatment of Alzheimer’s disease, Azilect for the treatment of Parkinson’s disease, Xenazine for the treatment of Huntington’s disease and Sabril for the treatment of epilepsy, among others. The Company operates through a number of subsidiaries, such as Lundbeck SAS, Lundbeck GmbH, SIA Lundbeck Latvia and Lundbeck LLC.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellNeutralBuyStrong BuySell
Technical IndicatorsStrong SellStrong SellStrong BuyStrong BuyStrong Sell
SummaryStrong SellSellStrong BuyStrong BuyStrong Sell
  • Why are financials not available? Please amend.
    0
    • Message to investing.com: This stock has a wrong name in the header. It is H Lundbeck A (not B)
      0